Breakthrough Patented Diet and
Exercise Mimetic Pill

ByzeptaTM: Patented and Proprietary Combination of Endogenous GLP-1 and UCP-1 Activators

  • Increases GLP-1 levels endogenously thereby improving insulin sensitivity and increasing SHBG levels.
  • Regulates the HPO axis thereby modulating the GnRH pulsatility and decreasing testosterone levels upto 33%.
  • Upregulates UCP-1 expression levels by 8.8 folds in the body thereby increasing mitochondrial biogenesis.
  • Converts WAT to BAT and increases thermogenesis, thereby reducing the total body fat upto 40%.
  • Improves ovarian cyclicity with no estrogenic effect, and increases the number of mature follicles.

Disclaimer: Above data / claim is based on the clinical evidence obtained from GLP-1 RA, UCP-1 and individual API molecules, Individual Results may vary*

ByzeptaTM is a diet and exercise mimetic pill for PCOS management by controlling insulin resistance and metabolic syndrome.

Quick Links

Contact Details

© Copyright 2025 Celagenex LLC. All Right Reserved. Website Designed by Enthof